Robin Swartz - 23 Dec 2024 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role: COO&CBO
Signature: /s/ Scott MacDonald, as Attorney-in-Fact for Robin Swartz
Issuer symbol: VYGR
Transactions as of: 23 Dec 2024
Net transactions value: -$36,725
Form type: 4
Filing time: 26 Dec 2024, 16:29:44 UTC
Previous filing: 03 Apr 2024
Next filing: 15 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYGR	Common Stock	Sale	$36,725	-6,500	-5.5%	$5.65	112,328	23 Dec 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.62 to $5.70, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2	Includes 1,824 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan on June 28, 2024.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.62 to $5.70, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Includes 1,824 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan on June 28, 2024.